Jan Skvarka, Director of Zentalis Pharmaceuticals ZNTL, has filed 1 purchase and 1 sale on the open market. The latest trade was on 06/16.

JS

JS

Jan Skvarka

Director

Company

Zentalis Pharmaceuticals ZNTL

First filing

23/03/31

Trades

11 trades

Buys / sales

1 / 1

12-month net buying

No record

Last trade

06/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Zentalis PharmaceuticalsZNTL	Open-market buy	25/01/31	25/02/04	60,000 sh	$1.72	$103,200	+67.0%
Zentalis PharmaceuticalsZNTL	Open-market sale10b5-1 plan	23/09/11	23/09/13	5,000 sh	$25.05	$125,250	−9.4%